AI assistant
Sending…
AGENUS INC — Director's Dealing 2010
Sep 14, 2010
34023_dirs_2010-09-14_7b1a9a16-9bc8-49e2-a4b9-8e38343cde4f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANTIGENICS INC /DE/ (agen)
CIK: 0001098972
Period of Report: 2010-09-10
Reporting Person: Wentworth Kerry (Vp, Clin, Reg & Quality)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-09-10 | Common Stock | A | 5000 | $0.93 | Acquired | 145541 | Direct |
| 2010-09-14 | Common Stock | S | 1453 | $0.9051 | Disposed | 144088 | Direct |
Footnotes
F1: Represents settlement of restricted stock awarded September 10, 2008.
F2: Represents shares sold to cover minimum federal, state, and local tax withholding requirements upon the vesting of the restricted shares awarded on September 10, 2008.
More from AGENUS INC
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Legal Proceedings Report
2026
Mar 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 26
Major Shareholding Notification
2026
Jan 23